Franchette van den Berkmortel

Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome

D.J.A. Lobbezoo, Roel J.W. van Kampen, Adri C. Voogd et al. · Breast Cancer Research and Treatment · 2013 · 239 citations

Breast Oncology, Medicine, Pathology +7

Response to Imported Case of Marburg Hemorrhagic Fever, the Netherlands

Aura Timen, Marion Koopmans, Ann C.T.M. Vossen et al. · Emerging infectious diseases · 2009 · 187 citations · Full text

Virus Epidemiology, Global Health, Pathogenesis +14

Functional status decline in older patients with breast and colorectal cancer after cancer treatment: A prospective cohort study

Doris van Abbema, Arnée van Vuuren, Franchette van den Berkmortel et al. · Journal of Geriatric Oncology · 2017 · 77 citations · Full text

A Model to Predict Pathologic Complete Response of Axillary Lymph Nodes to Neoadjuvant Chemo(Immuno)Therapy in Patients With Clinically Node-Positive Breast Cancer

Robert‐Jan Schipper, M. Moossdorff, Patty J. Nelemans et al. · Clinical Breast Cancer · 2014 · 52 citations

Breast Oncology, Medicine, Immunology +7

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill et al. · European Journal of Cancer · 2017 · 46 citations

Breast Oncology, Medicine, Primary Analysis +7